These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11991509)

  • 41. Overexpression of Interleukin-1α Suppresses Liver Metastasis of Lymphoma: Implications for Antitumor Effects of CD8+ T-cells.
    Udagawa K; Niki Y; Kikuchi T; Fukuhara Y; Takeda Y; Miyamoto T; Matsumoto M; Nakamura M
    J Histochem Cytochem; 2021 Apr; 69(4):245-255. PubMed ID: 33559519
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interleukin-12 gene transfer results in CD8-dependent regression of murine CT26 liver tumors.
    Weber SM; Shi F; Heise C; Warner T; Mahvi DM
    Ann Surg Oncol; 1999 Mar; 6(2):186-94. PubMed ID: 10082045
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adenovirus-mediated interleukin-18 mutant in vivo gene transfer inhibits tumor growth through the induction of T cell immunity and activation of natural killer cell cytotoxicity.
    Hwang KS; Cho WK; Yoo J; Seong YR; Kim BK; Kim S; Im DS
    Cancer Gene Ther; 2004 Jun; 11(6):397-407. PubMed ID: 15044962
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chemo-adoptive immunotherapy of nude mice implanted with human colorectal carcinoma and melanoma cell lines.
    Gazit Z; Weiss DW; Shouval D; Yechezkeli M; Schirrmacher V; Notter M; Walter J; Kedar E
    Cancer Immunol Immunother; 1992; 35(2):135-44. PubMed ID: 1596937
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
    Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
    Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Murine liver metastasis model using L5178Y-ML lymphoma and the effect of antitumor agents on the metastasis.
    Watanabe Y; Okura A; Naito K; Kobayashi M
    Jpn J Cancer Res; 1988 Nov; 79(11):1208-16. PubMed ID: 3147276
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vivo antitumor activity of NKT cells activated by the combination of IL-12 and IL-18.
    Baxevanis CN; Gritzapis AD; Papamichail M
    J Immunol; 2003 Sep; 171(6):2953-9. PubMed ID: 12960319
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The function and role of extrathymic T cells].
    Seki S; Takeda K; Abo T
    Nihon Rinsho; 1995 Nov; 53(11):2846-57. PubMed ID: 8538054
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IFN-gamma-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones.
    Tsutsui H; Nakanishi K; Matsui K; Higashino K; Okamura H; Miyazawa Y; Kaneda K
    J Immunol; 1996 Nov; 157(9):3967-73. PubMed ID: 8892629
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The administration of naked plasmid DNA into the liver induces antitumor innate immunity in a murine liver metastasis model.
    Yonenaga Y; Mori A; Fujimoto A; Nagayama S; Tachibana T; Onodera H; Uemoto S
    J Gene Med; 2007 Apr; 9(4):299-307. PubMed ID: 17397091
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Administration of interleukin-12 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines in mouse hepatocellular carcinoma.
    Tatsumi T; Takehara T; Kanto T; Miyagi T; Kuzushita N; Sugimoto Y; Jinushi M; Kasahara A; Sasaki Y; Hori M; Hayashi N
    Cancer Res; 2001 Oct; 61(20):7563-7. PubMed ID: 11606395
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Isolation and characterization of a metastatic Eb-like tumor variant highly responsive to interleukin (IL)-2 and to combination cytokine therapy with IL-2/IL-1 beta and IL-1 beta/interferon-alpha/beta.
    Gabriele L; Proietti E; Greco G; Venditti M; Gresser I; Schirrmacher V; Von Hoegen P; Testa U; Modesti A; Cianfriglia M
    Invasion Metastasis; 1993; 13(3):147-62. PubMed ID: 8112975
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combined GM-CSF and IL-12 gene therapy synergistically suppresses the growth of orthotopic liver tumors.
    Chang CJ; Chen YH; Huang KW; Cheng HW; Chan SF; Tai KF; Hwang LH
    Hepatology; 2007 Mar; 45(3):746-54. PubMed ID: 17326190
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recombinant human prolactin improves antitumor effects of murine natural killer cells in vitro and in vivo.
    Sun R; Wei H; Zhang J; Li A; Zhang W; Tian Z
    Neuroimmunomodulation; 2002-2003; 10(3):169-76. PubMed ID: 12481157
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Postoperative administration of interleukin-12 significantly enhances the anti-tumor immune response of MBT-2 bladder cancer bearing mice.
    Tzai TS; Shiau AL; Wu CL; Tsai YS
    Proc Natl Sci Counc Repub China B; 2000 Apr; 24(2):56-62. PubMed ID: 10809081
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antitumor and antimetastatic effects of interleukin 12.
    Fujiwara H; Hamaoka T
    Cancer Chemother Pharmacol; 1996; 38 Suppl():S22-6. PubMed ID: 8765411
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytokine production and killer activity of NK/T-NK cells derived with IL-2, IL-15, or the combination of IL-12 and IL-18.
    Lauwerys BR; Garot N; Renauld JC; Houssiau FA
    J Immunol; 2000 Aug; 165(4):1847-53. PubMed ID: 10925263
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Curative effects of combination therapy with lentinan and interleukin-2 against established murine tumors, and the role of CD8-positive T cells.
    Suzuki M; Kikuchi T; Takatsuki F; Hamuro J
    Cancer Immunol Immunother; 1994 Jan; 38(1):1-8. PubMed ID: 8299113
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multiple roles of interferon-gamma in the mediation of interleukin 12-induced tumor regression.
    Ogawa M; Yu WG; Umehara K; Iwasaki M; Wijesuriya R; Tsujimura T; Kubo T; Fujiwara H; Hamaoka T
    Cancer Res; 1998 Jun; 58(11):2426-32. PubMed ID: 9622084
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antimetastatic effect of NK1+ T cells on experimental haematogenous tumour metastases in the liver and lungs of mice.
    Seki S; Hashimoto W; Ogasawara K; Satoh M; Watanabe H; Habu Y; Hiraide H; Takeda K
    Immunology; 1997 Dec; 92(4):561-6. PubMed ID: 9497499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.